ZA9010353B - Spray drying process for making pharmaceutical powder compositions directly compressible into tablets - Google Patents

Spray drying process for making pharmaceutical powder compositions directly compressible into tablets

Info

Publication number
ZA9010353B
ZA9010353B ZA9010353A ZA9010353A ZA9010353B ZA 9010353 B ZA9010353 B ZA 9010353B ZA 9010353 A ZA9010353 A ZA 9010353A ZA 9010353 A ZA9010353 A ZA 9010353A ZA 9010353 B ZA9010353 B ZA 9010353B
Authority
ZA
South Africa
Prior art keywords
tablets
powder compositions
drug
spray drying
directly compressible
Prior art date
Application number
ZA9010353A
Other languages
English (en)
Inventor
Roy Kuramoto
Kuramoto Roy
Zakauddin Tanwir Chowhan
Tanwir Chowhan Zakauddin
Randal Owen Pendleton
Owen Pendleton Randal
Hafez Hafezzadeh
Hafezzadeh Hafez
Original Assignee
Syntex Pharma Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Pharma Int filed Critical Syntex Pharma Int
Publication of ZA9010353B publication Critical patent/ZA9010353B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9010353A 1989-12-22 1990-12-21 Spray drying process for making pharmaceutical powder compositions directly compressible into tablets ZA9010353B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45510989A 1989-12-22 1989-12-22

Publications (1)

Publication Number Publication Date
ZA9010353B true ZA9010353B (en) 1992-08-26

Family

ID=23807439

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9010353A ZA9010353B (en) 1989-12-22 1990-12-21 Spray drying process for making pharmaceutical powder compositions directly compressible into tablets

Country Status (16)

Country Link
EP (1) EP0436373B1 (fi)
JP (1) JPH05320045A (fi)
KR (1) KR910011241A (fi)
AT (1) ATE110267T1 (fi)
AU (1) AU640725B2 (fi)
CA (1) CA2032956A1 (fi)
DE (1) DE69011836T2 (fi)
ES (1) ES2063296T3 (fi)
FI (1) FI906372A (fi)
HU (1) HUT59594A (fi)
IE (1) IE904666A1 (fi)
IL (1) IL96749A0 (fi)
NO (1) NO905557L (fi)
NZ (1) NZ236631A (fi)
PT (1) PT96229B (fi)
ZA (1) ZA9010353B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2136659T3 (es) * 1992-04-15 1999-12-01 Alteon Inc Procedimiento de secado por pulverizacion de aminoguanidina.
AU5135898A (en) * 1996-12-03 1998-06-29 Schering-Plough Kabushiki Kaisha Controlled release matrix tablet and method for its preparation
KR100611855B1 (ko) * 2001-07-30 2006-08-11 디에스엠 아이피 어셋츠 비.브이. 에피갈로카테킨 갈레이트용 조성물
CN1309370C (zh) 2002-02-01 2007-04-11 辉瑞产品公司 使用改进的喷雾干燥设备制备均匀喷雾干燥的固体非晶形药物分散体的方法
US7704528B2 (en) * 2003-05-05 2010-04-27 Isp Investments Inc. Binder composition and method for processing poorly compressible drugs into tablets of predetermined hardness and friability
CL2004001884A1 (es) * 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
PE20050445A1 (es) * 2003-10-30 2005-06-18 Bayer Consumer Care Ag Forma de presentacion del naproxeno sodico
JP2008222567A (ja) * 2007-03-08 2008-09-25 Iwate Univ 微粒子の製造方法
TW201113266A (en) * 2009-09-02 2011-04-16 Ziopharm Oncology Inc Pharmaceutical formulations for indibulin
IE20100799A1 (en) * 2010-12-22 2012-08-01 Eurand Pharmaceuticals Ltd Pharmaceutical composites of poorly water soluble drugs and polymers
TWI721997B (zh) * 2015-07-13 2021-03-21 日商協和發酵生化股份有限公司 含高含量精胺酸之錠劑
JP6619644B2 (ja) * 2015-12-22 2019-12-11 アサヒグループ食品株式会社 錠剤の製造方法、及び錠剤原料用顆粒の製造方法
JP7163015B2 (ja) * 2016-10-31 2022-10-31 エスエス製薬株式会社 経口固形組成物
KR20220054349A (ko) * 2019-08-26 2022-05-02 디에스엠 아이피 어셋츠 비.브이. 나프록센 및 비타민 b12를 포함하는 고체 경구 투여 형태

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4744987A (en) * 1985-03-08 1988-05-17 Fmc Corporation Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation
US4753801A (en) * 1985-10-25 1988-06-28 Eli Lilly And Company Sustained release tablets
IE61676B1 (en) * 1987-07-08 1994-11-30 American Home Prod Spray dried ibuprofen composition
IT1226549B (it) * 1988-07-12 1991-01-24 Resa Farma Composizioni farmaceutiche ad attivita' analgesica ed antiinfiammatoria per uso orale, dotate di ottima palatabilita' ed esenti da effetti irritanti sulle mucose.

Also Published As

Publication number Publication date
CA2032956A1 (en) 1991-06-23
ES2063296T3 (es) 1995-01-01
DE69011836D1 (de) 1994-09-29
FI906372A (fi) 1991-06-23
PT96229B (pt) 1998-06-30
FI906372A0 (fi) 1990-12-21
JPH05320045A (ja) 1993-12-03
AU6837590A (en) 1991-06-27
IL96749A0 (en) 1991-09-16
NO905557L (no) 1991-06-24
NO905557D0 (no) 1990-12-21
ATE110267T1 (de) 1994-09-15
KR910011241A (ko) 1991-08-07
HUT59594A (en) 1992-06-29
EP0436373B1 (en) 1994-08-24
IE904666A1 (en) 1991-07-17
NZ236631A (en) 1993-03-26
EP0436373A1 (en) 1991-07-10
HU908395D0 (en) 1991-07-29
DE69011836T2 (de) 1995-03-09
PT96229A (pt) 1991-09-30
AU640725B2 (en) 1993-09-02

Similar Documents

Publication Publication Date Title
AU640725B2 (en) Spray drying process for making pharmaceutical powder compositions directly compressible into tablets
KR880004805A (ko) 분무건조된 아세트아미노펜
ATE66141T1 (de) Pharmazeutische zusammensetzung.
DE3877764D1 (de) Ein freifliessendes granulat, enthaltend ibuprofen und ein herstellunsgverfahren.
ATE125155T1 (de) Niedrigdosierte getrocknete pharmazeutische präparate.
CA2277913A1 (en) New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof
JPS5753403A (en) Composition containing spray dry particle of n-acetyl-p-aminophenol and manufacture
US5534551A (en) Aminoguanidine spray drying process
CA1268706A (en) Method for simultaneously drying and granulating extract substances from deproteinized calves blood
JPS5474855A (en) Preparation of finely divided soluble cellulose derivative
GB1506345A (en) Multitioned tablets
US5185336A (en) Method for producing substantially pure vitamin powders
CZ286197B6 (cs) Příprava tablet kyseliny fusidové
JPS557236A (en) Preparation of powdery sodium acetate (anhydrous)
RU2105547C1 (ru) Анальгезирующее жаропонижающее средство и способ его получения
RU2195286C1 (ru) Твердая лекарственная форма, содержащая глицирам
RU98115790A (ru) Способ получения таблеток ранитидина
RU97106462A (ru) Способ получения таблетированной формы препарата
JPS56156214A (en) Preparation of tableting enteric microcapsule
KR900000075A (ko) 장용성 과립제의 제조방법